Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-23-003464

Options or other derivatives

  • CIO & SVP acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sekulich George CIO & SVP 2023-01-12 Grant or award · Options +100,000 $4.50 $450,000 100,000 D
Loading xslF345X03/doc4.xml…